Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

COLORADO, USA — After learning a veteran DNA analyst at the Colorado Bureau of Investigation (CBI) manipulated data in more ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.

KPRC 2 Investigates is looking into why people end up with bills for hundreds even thousands of dollars for a simple covid test. By federal law covid tests are free regardless of having insurance. So ...

AT&T, T-Mobile, and Verizon offer free trials with eSIM, so you can see if the network is a good fit where you live without ...

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

Exact Sciences' Q3 report led to a ~25% drop in share price, due to a slight guidance cut and narrow revenue miss. Learn more ...

Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.

Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...

Exact Sciences Corp ( (EXAS) ) has released its Q3 earnings. Here is a breakdown of the information Exact Sciences Corp presented to its ...

The biomedical giant best known for its Cologuard at-home colon cancer screening test reported a loss of $38.2 million, or $0.21 per share, on revenue of $708.7 million.

Hello. At this time, I would like to welcome everyone to the Exact Sciences. Third quarter, 2024 earnings conference call. (Operator Instructions) I would now like to turn the call over to Erik ...